We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.

Research at CPC-M - Biosamples – raw material for research

Research at CPC-M

Biosamples – raw material for research

Asklepios Biobank for Lung Diseases

How tissue samples from lung tumor patients advance research

The aim of biobanks is to collect, store and make available high-quality samples of tissue, blood and other body fluids for scientific research.

The German Center for Lung Research (DZL) has several biobanks that focus on specific diseases. At the DZL site in Munich (Comprehensive Pneumology Center Munich), the Asklepios biobank in Gauting focuses on lung tumors and non-malignant diseases of the lungs. 

Since 2008, samples of lung tissue, mostly tumor tissue and the surrounding normal lung tissue have been freshly frozen in liquid nitrogen and archived there. In addition, there are blood samples from tumor patients and patients with other lung diseases. Since then, around 4,000 patients have provided the biobank with tissue or blood taken during surgery or for diagnostic purposes. This is what is known as residual tissue, which remains after completion of all diagnostic procedures. 

Lab Work at Asklepios Biobank
Lab Work at Asklepios Biobank

All new patients admitted to the Asklepios Clinic are informed about the biobank and asked to provide their biosamples. Although lung cancer is one of the most common types of cancer, relatively little tissue is available for research.

 

One reason: many lung cancer patients are no longer treated surgically, but undergo chemotherapy immediately. Only in relatively early stages can the affected lung lobe be surgically removed with the tumor. 

Scientists can use this material for medical research. Each withdrawal request is reviewed by an ethics committee. The Ethics Committee has confirmed that the Asklepios Biobank for Lung Diseases is ethically and legally acceptable.

The DZL has also established a centrally organized biobanking platform, in which scientists from all DZL sites work together. External researchers shall also have access to biomaterials. The goal: optimal conditions for the research and development of new therapies for lung diseases. 

Overview of biobanks in the German Center for Lung Research
 

Head of Group

Dr. Ina Koch

Asklepios Biobank für Lungenerkrankungen
Plattform Biobank im Comprehensive Pneumology Center CPC-M – Deutsches Zentrum für Lungenforschung DZL
Robert-Koch-Allee 2

82131 Gauting
 
Telephone +49 89 85791 - 4210
Email: ina.koch(at)asklepios.com

Team

Dr. Michael Lindner, Head Senior Physician of Thoracic Surgery

(above, from left to right)

Carleen Kirchhoff, MTA Pathology
Dr. Elvira Stacher-Priehse, Pathologist
Klara Fizi, MTA Biobank
Susanne Ehret, MTA Biobank and Pathology
Diana Steinhardt, MTA
Dr. Ina Koch, Head of Group
Patrizia Sklarek (until 2018)

 

We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.